In the dynamic landscape of the NASDAQ, discerning investors are constantly on the lookout for stocks that are not just promising but undervalued—a golden opportunity to buy low and, with patience, sell high. The allure of undervalued stocks is not just in their potential for future growth but also in the thrill of discovering hidden […]
Investor’s Guide: The Top 3 Stocks to Own as Markets Turn Bullish
Aline Medeiros | February 22, 2024
The stock market’s landscape has witnessed a dramatic transformation from the bearish outlook of 2022 to a bullish sentiment in 2023, characterized by a significant pivot towards growth stocks.
Strategic Hedging in 2024: Protecting Gains in an Unpredictable Market
Aline Medeiros | February 21, 2024
In the dynamic landscape of the financial markets, a nuanced strategy for investors to protect their gains amidst a seemingly overheated stock market emerges.
Home Depot’s Performance Amidst Rising Mortgage Rates
Aline Medeiros | February 20, 2024
Home Depot’s Fourth-Quarter Foresight In the latest financial quarter, Home Depot encountered significant headwinds, as the
Wall St edges up with earnings, rate-cut expectations in focus
reuters | February 6, 2024
By Johann M Cherian and Ankika Biswas (Reuters) – Wall Street’s main indexes inched higher on Tuesday as investors parsed big-ticket earnings and awaited commentary from policymakers for clues on the timing of the Federal Reserve’s first interest-rate cut. Eli Lilly jumped 3.5% after forecasting 2024 profit above estimates, driven by demand for its blockbuster […]
Lilly expects strong 2024 profit on rising weight-loss drug demand
reuters | February 6, 2024
By Patrick Wingrove and Bhanvi Satija (Reuters) -Eli Lilly on Tuesday forecast 2024 profit above Wall Street estimates on soaring demand for its recently approved weight-loss drug, and said the treatment helped reduce symptoms of a common, difficult to treat fatty liver disease in a mid-stage trial. The company said it expects 2024 revenue of […]
Wall Street equities fall with interest rates, earnings in focus
reuters | February 6, 2024
By Sinéad Carew and Johann M Cherian (Reuters) -Wall Street’s main indexes closed lower on Monday after Federal Reserve Chair Jerome Powell pushed back firmly against speculation that rate cuts would be imminent, while investors assessed a mixed bag of U.S. earnings reports. In an interview aired on Sunday, Powell said more evidence on a […]
Nvidia eyes fresh record as Goldman Sachs bullish on AI prospects
reuters | February 5, 2024
(Reuters) – Nvidia’s shares were set to scale a new peak on Monday after Goldman Sachs raised its price target for the high-flying chipmaker’s stock in anticipation of a major boost to its earnings from the artificial intelligence (AI) boom. The stock rose 3.4% to $683.80 in premarket trading and looked set to add about […]
AbbVie raises 2027 sales forecast for new immunology drugs to $27 billion
reuters | February 2, 2024
By Leroy Leo and Patrick Wingrove (Reuters) -AbbVie on Friday raised its 2027 forecast for sales of its immunology drugs Skyrizi and Rinvoq to $27 billion, up $6 billion from its previous prediction. The Chicago-based drugmaker has been counting on revenues from its newer immunology medicines to help make up for declining sales of blockbuster […]
Musk seeks Tesla shareholder vote on moving incorporation to Texas
reuters | February 1, 2024
By Shubham Kalia, Maria Ponnezhath and Samrhitha A (Reuters) – Tesla CEO Elon Musk said on Thursday the company will hold a shareholder vote to transfer its state of incorporation to Texas from Delaware, days after a judge invalidated his $56 billion pay package at the electric vehicle (EV) maker. On Tuesday, Delaware judge Kathaleen […]